{'fraction_non_alphanumeric': 0.022007042253521125, 'fraction_numerical': 0.011443661971830986, 'mean_word_length': 5.145945945945946, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Consensus Statement from the U.S. National Institutes of Health (NIH): Intravenous Immunoglobulin: Prevention and Treatment of Disease

must have intensive guidance. The patient must be informed in no uncertain terms of the importance of limiting or stopping smoking. Selective action to identify persons with hereditary hypercholesterolemia and persons with a high cholesterol level plus additional risk factors costs time and money. The general practitioner will be unable to perform this task without the provision of extra facilities. The committee wishes to draw attention to this problem. It is urgent that a (legal) means be created soon to stop the proliferation of the "detached" testing of serum cholesterol levels, such as exists in the United States, where the Food and Drug Administration employs a restrictive policy with respect to cholesterol tests. Most of the conclusions and recommendations of the cholesterol committee have been translated into governmental policies during 1990. Copies of the full report may be ordered from The Health Council of the Netherlands, P.O. Box 90517, 2509 LM The Hague, the Netherlands.